Bull of the Day: Lam Research (LRCX)

Lam Research (LRCX) reported its 14th consecutive quarterly earnings beat for the period ending September 28, 2025, with EPS of $1.26 against a $1.21 consensus and revenue surging 27.6% to $5.32 billion, alongside an improved gross margin of 50.6%. Analysts have subsequently raised FY2026 and FY2027 earnings estimates, projecting double-digit growth, which has propelled LRCX shares to new all-time highs, up 109.4% year-to-date, despite a forward P/E of 32.4 indicating a premium valuation for its anticipated growth.

Analysis

Lam Research (LRCX) reported its 14th consecutive quarterly earnings beat for the period ending September 28, 2025, with EPS of $1.26 exceeding the $1.21 consensus. Revenue surged 27.6% year-over-year to $5.32 billion, driven significantly by China (43% of revenue), while gross margin improved to 50.6% from 48%. This consistent outperformance underscores strong operational execution and robust demand within the semiconductor equipment sector.

Analysts have responded positively, with 8 estimates for fiscal 2026 and 4 for fiscal 2027 revised higher in the past week. The Zacks Consensus for FY2026 EPS rose to $4.68 (13% growth) and for FY2027 to $5.44 (16.1% growth), reflecting anticipated double-digit sales growth of 11.9% and 11.7% respectively. This upward revision in future earnings and sales forecasts signals sustained confidence in LRCX's long-term trajectory.

LRCX shares have responded strongly, reaching new all-time highs in 2025, with an 18.2% gain in the last month and a 109.4% year-to-date increase. Despite this significant appreciation, the stock trades at a forward P/E of 32.4, which is considered expensive relative to a P/E over 20. The current valuation reflects investor willingness to pay a premium for the company's strong growth prospects and consistent performance.

Key Decisions for Investors

• Investors should closely monitor the sustainability of Lam Research's projected double-digit sales and earnings growth for FY2026 and FY2027, as the current premium valuation (forward P/E of 32.4) is largely priced on these expectations.
• Evaluate potential geopolitical risks and trade policy changes, particularly concerning the significant 43% revenue contribution from China, which could impact future revenue streams.
• While the stock's strong momentum (109.4% YTD gain, new all-time highs) indicates robust investor sentiment, consider the elevated valuation and potential for short-term corrections when assessing new positions.